Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Detailed mapping of chromosome 17p deletions reveals HIC1 as a novel tumor suppressor gene candidate telomeric to TP53 in diffuse large B-cell lymphoma

Published:2007-11-05 Issue:18 Volume:27 Page:2613-2625
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Stöcklein H,Smardova J,Macak J,Katzenberger T,Höller S,Wessendorf S,Hutter G,Dreyling M,Haralambieva E,Mäder U,Müller-Hermelink H K,Rosenwald A,Ott G,Kalla J

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1210901.pdf

Reference58 articles.

1. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. (2000). Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503–511.

2. Bea S, Zettl A, Wright G, Salaverria I, Jehn P, Moreno V et al. (2005). Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction. Blood 106: 3183–3190.

3. Britschgi C, Rizzi M, Grob TJ, Tschan MP, Hugli B, Reddy VA et al. (2006). Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 25: 2030–2039.

4. Chen CM, Behringer RR . (2004). Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev 18: 320–332.

5. Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M et al. (2004). Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell 6: 387–398.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Cytogenetic Profiling Reveals Similarities and Differences Between Localized Nodal and Systemic Follicular Lymphomas;HemaSphere;2022-08-10

2. From Anti-EBV Immune Responses to the EBV Diseasome via Cross-reactivity;Global Medical Genetics;2020-08

3. Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer;BMC Cancer;2019-12

4. Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma;BMC Medical Genomics;2019-03

5. LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity;Experimental Cell Research;2018-09